Key result
Trans-radial intervention consistently lowered the odds of PCI-related bleeding compared with no bleeding avoidance strategy across all risk strata.
Why the study?
Procedural anticoagulation with bivalirudin, trans-radial intervention, and vascular closure devices are thought to mitigate PCI-related bleeding, but their impact across strata of predicted bleeding risk required comparison.
Do bleeding avoidance strategies (bivalirudin, trans-radial intervention, vascular closure device) reduce PCI-related bleeding across different predicted risk strata compared to no bleeding avoidance strategies?
Cohort (n=74,953)
Yes
Do bleeding avoidance strategies (bivalirudin, trans-radial intervention, vascular closure device) reduce PCI-related bleeding across different predicted risk strata compared to no bleeding avoidance strategies?
Trans-radial intervention is the only individual bleeding avoidance strategy that consistently reduces PCI-related bleeding across all predicted risk strata.
Answers are grounded in this paper and cite their sources.
Trans-radial access may lower PCI bleeding across risk strata; extends observational data but leaves randomized confirmation open.
BACKGROUND: Procedural anticoagulation with bivalirudin (BIV), trans-radial intervention (TRI), and use of a vascular closure device (VCD) are thought to mitigate percutaneous coronary intervention (PCI)-related bleeding. We compared the impact of these bleeding avoidance strategies (BAS) for PCIs stratified by bleeding risk. METHODS: We performed a retrospective cohort analysis of PCIs from 18 facilities within one health care system from 2009Q3 to 2017Q4. Bleeding risk was assessed per the National Cardiovascular Data Registry CathPCI bleeding model, with procedures stratified into 6 categories (first, second, third quartiles, 75th-90th, 90th-97.5th, and top 2.5th percentiles). Regression models were used to assess the impact of BAS on bleeding outcome. RESULTS: Of 74 953 PCIs, 9.4% used no BAS, 12.0% used BIV alone, 20.8% used TRI alone, 26.8% used VCD alone, 5.4% used TRI+BIV, and 25.6% used VCD+BIV. The crude bleeding rate was 4.4% overall. Only 2 comparisons showed significant trends across all risk strata: VCD+BIV versus no BAS, odds ratio (95% CI) range: first quartile, 0.36 (0.18-0.72) to top 2.5th percentile, 0.50 (0.32-0.78); TRI versus no BAS, odds ratio (95% CI) range: first quartile, 0.15 (0.06-0.38) to top 2.5th percentile, 0.49 (0.28-0.86). TRI had lower odds of bleeding compared with BIV for all risk strata except the top 2.5th percentile. Addition of BIV to TRI did not change the odds of bleeding for any risk strata. Factors potentially limiting use of TRI (renal failure, shock, cardiac arrest, and mechanical circulatory support) were present in ≤10% of procedures below the 90th percentile. CONCLUSIONS: Among individual BAS, only TRI had consistently lower odds of bleeding across all risk strata. Factors potentially limiting TRI were found infrequently in procedures below the 90th percentile of bleeding risk. For transfemoral PCI, VCD+BIV had lower odds of bleeding compared with no BAS across all risk strata.
No takes yet. Share an insight, caveat, or question.
Gluckman et al. (2020) conducted a cohort in Percutaneous coronary intervention (PCI) (n=74,953). Trans-radial intervention (TRI) vs. No bleeding avoidance strategy (BAS) was evaluated on PCI-related bleeding (OR 0.15 to 0.49, 95% CI 0.06-0.38 to 0.28-0.86). Trans-radial intervention consistently lowered the odds of PCI-related bleeding compared with no bleeding avoidance strategy across all risk strata.
Synapse has enriched 10 related papers. Consider them for comparative context: